This company has no dividend history.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
No dividend history found in SEC filings.
Does Nuvalent (NUVL) pay a dividend?
Nuvalent (NUVL) has never paid a dividend. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does Nuvalent (NUVL) pay a dividend?+
No. Nuvalent (NUVL) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.
How does Nuvalent return cash to shareholders?+
It largely does not. Nuvalent pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Nuvalent.
SourceDividend analysis computed from the 10-Q filed 7 May 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 4 Sept 2026. How this is calculated.
Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.
Peers
Pharmaceutical Preparations · Pick stocks to compare with NUVL
Held by ETFs
NUVL is in 12 US ETFs. The largest of them, with NUVL's weight in each:
John Hancock Multifactor Mid Cap ETFJHMM0.04%of the fund
Fidelity Enhanced Small Cap ETFFESM0.11%of the fund
Avantis U.S. Large Cap Equity ETFAVLC0.01%of the fund
Invesco Dorsey Wright SmallCap Momentum ETFDWAS0.99%of the fund
- CATema Oncology ETFCANC3.37%of the fund
- RURussell Investments U.S. Small Cap Equity Active ETFRUSC0.26%of the fund
Spot a number that looks wrong? Check it in NUVL's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NUVL
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.